The product is expected to be available in the first half of 2026. The Food and Drug Administration (FDA) has approved Bondlido ® (lidocaine topical system 10%) for the relief of pain associated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback